|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues from sale of products | |||||
| Revenues from development services | |||||
| Revenues from license agreements and royalties | |||||
| Total revenues | |||||
| Cost of revenues from sale of products | |||||
| Cost of revenues from development services | |||||
| Cost of revenues from license agreements and royalties | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Other (income) expenses | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Finance income | |||||
| Finance expense | |||||
| Financing income (expenses), net | |||||
| Loss before taxes on income | |||||
| Taxes on income | |||||
| Net loss | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustments | |||||
| Total comprehensive loss | |||||
| Loss per share data: | |||||
| Basic net loss per share | |||||
| Diluted net loss per share | |||||
| Number of shares used in calculating basic loss per share | |||||
| Number of shares used in calculating diluted loss per share | |||||
Loading...